Bone Tumor Clinical Trials

6 recruiting

Bone Tumor Trials at a Glance

10 actively recruiting trials for bone tumor are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Hangzhou, Beijing, and Bologna. Lead sponsors running bone tumor studies include Second Affiliated Hospital, School of Medicine, Zhejiang University, Shanghai Yunying Medical Technology, and Istituto Ortopedico Rizzoli.

Browse bone tumor trials by phase

Treatments under study

About Bone Tumor Clinical Trials

Looking for clinical trials for Bone Tumor? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bone Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bone Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery

OsteosarcomaEwing SarcomaChondrosarcoma+1 more
Istituto Ortopedico Rizzoli50 enrolled1 locationNCT05779670
Recruiting
Phase 1

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer
Telix Pharmaceuticals (Innovations) Pty Limited33 enrolled3 locationsNCT07197645
Recruiting
Not Applicable

"Multicenter Registry for Chest Wall Reconstruction Using Custom Dynamic Prostheses (PRODIPET)"

Chest Wall TumorsPost-traumatic SyndromeMalignant Bone Tumor of Chest Wall
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal60 enrolled5 locationsNCT07018960
Recruiting
Not Applicable

A Substudy of the Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery

Bone TumorAcute Normovolemic HemodilutionGoal-Directed Fluid Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University32 enrolled1 locationNCT06881498
Recruiting

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

Bone CancerBone Tumor
Costantino Errani150 enrolled1 locationNCT06486506
Recruiting
Not Applicable

The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery

TransfusionBone TumorAcute Normovolemic Hemodilution+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT06459141
Recruiting
Not Applicable

Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells

Malignant Bone Tumor
Peking University People's Hospital60 enrolled1 locationNCT06302465
Recruiting
Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors

Soft Tissue SarcomaSarcomaOsteosarcoma+1 more
Shanghai Yunying Medical Technology9 enrolled1 locationNCT06171282
Recruiting

En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.

SurgeryRadiotherapySpinal Metastases+2 more
Shanghai Changzheng Hospital182 enrolled1 locationNCT06120426
Recruiting
Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

SarcomaOsteosarcomaSarcoma,Soft Tissue+1 more
Shanghai Yunying Medical Technology20 enrolled1 locationNCT05851456